First NHS patient receives Chiesi’s advanced-therapy-medicinal product, Holoclar for moderate-to-severe limbal stem cell deficiency

First NHS patient receives Chiesi’s advanced-therapy-medicinal product, Holoclar for moderate-to-severe limbal stem cell deficiency